[Antiresorptive therapy for osteoporosis and bone quality]
- PMID: 15930715
[Antiresorptive therapy for osteoporosis and bone quality]
Abstract
In high turnover osteoporosis antiresorptive therapy is effective in increasing the stiffness and the toughness (bone strength) by increasing the mean degree of mineralization of bone tissue through the prolongation of secondary mineralization. But the long-term use of antiresorber would result in highly mineralized bone and disturbed repair of microcracks by inhibition of bone remodeling. Intermittent use of antiresorber could be recommended to avoid the deterioration of bone quality.
Similar articles
-
[Bisphosphonate therapy for osteoporosis and bone strength].Clin Calcium. 2006 Sep;16(9):1513-19. Clin Calcium. 2006. PMID: 16951477 Review. Japanese.
-
[Effects of antiresorptive therapy on the structural and material properties of bone strength].Clin Calcium. 2016 Jan;26(1):107-15. Clin Calcium. 2016. PMID: 26728537 Review. Japanese.
-
[Assessment of bone quality. Bone quality and osteoporosis treatment].Clin Calcium. 2008 Mar;18(3):300-7. Clin Calcium. 2008. PMID: 18310816 Review. Japanese.
-
[Functional mechanism of glucocorticoid in bone turnover and bone structure].Clin Calcium. 2006 Nov;16(11):1805-11. Clin Calcium. 2006. PMID: 17079846 Review. Japanese.
-
Current and emerging therapies for osteoporosis.J Fam Pract. 2009 Jul;58(7 Suppl Osteoporosis):S45-9. J Fam Pract. 2009. PMID: 19825319 Review.
Publication types
MeSH terms
LinkOut - more resources
Medical